Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 19,765 full-time employees. The company went IPO on 2005-09-28. The firm is involved in the research, development, manufacture and sale of pharmaceuticals, as well as the provision of intermediates and basic materials for pharmaceutical producing in Japan, the United States, Europe and other markets. The firm is also engaged in the research, development, manufacture and sale of over-the-counter drugs and vaccines, the provision of administrative services such as human resources and accounting services, real estate leasing and insurance agency business.
Who is the CEO of Daiichi Sankyo Company, Limited?
Mr. Sunao Manabe is the Chairman of the Board of Daiichi Sankyo Company, Limited, joining the firm since 2012.
What is the price performance of Daiichi Sankyo Co., Ltd. stock?
The current price of Daiichi Sankyo Co., Ltd. is $18.92, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Daiichi Sankyo Company, Limited?
Daiichi Sankyo Company, Limited belongs to Pharmaceuticals industry and the sector is Health Care
What is Daiichi Sankyo Company, Limited market cap?
Daiichi Sankyo Company, Limited's current market cap is $34.9B
Is Daiichi Sankyo Company, Limited a buy, sell, or hold?
According to wall street analysts, 19 analysts have made analyst ratings for Daiichi Sankyo Company, Limited, including 8 strong buy, 11 buy, 1 hold, 0 sell, and 8 strong sell